FDA Approves Allergan’s Natrelle Inspira Implants
Breast augmentation surgery involves the surgical placement of saline or silicone gel based implants in the breast tissue to increase the size of the breasts. Silicone implants have become more popular over the years because of the pleasing aesthetics and natural looking touch and feel of these implants. Final results in breast augmentation can be impacted by the choice of implants.
An experienced plastic surgeon will closely engage with the patient to understand their personal aesthetic goals and recommend the most appropriate implant quality to meet those goals. Modern Body Contouring & Laser Center is a state of the art practice providing both surgical and non-invasive aesthetic procedures to patients in Northern Virginia, Washington DC, Vienna, McLean, Loudoun, Ashburn, Tysons Corner, Reston, Arlington, Chevy Chase, Richmond, and surrounding communities.
Implants by Allergan, Inc.
Allergan, Inc., which is being taken over by global pharmaceutical giant Actavis for $66 billion, is a leading company for medical products in the area of medical aesthetics, breast surgery aesthetics, non-invasive dermatology, neurosciences, urologics, and eye care. One of the most popular brands of Allergan is Botox, which is used worldwide as a wrinkle reduction treatment. Allergan sells billions of dollars worth of products every year all over the world.
The company has now introduced highly innovative and advanced silicone gel based round breast implants called Natrelle Inspira. These round shaped implants are designed to achieve the highest patient satisfaction levels for women who are looking to augment the appearance of breasts. Modern Body Contouring & Laser Center provides Allergan’s products to patients in Northern Virginia, Washington DC, Vienna, McLean, Loudoun, Ashburn, Tysons Corner, Reston, Arlington, Chevy Chase, Richmond, and nearby areas.
FDA Approval for Natrelle Inspira
Natrelle Inspira round gel-filled smooth breast implants have now been approved by the US Food and Drug Administration (FDA). According to Allergan, its Natrelle Inspira line is distinguished from other common breast implant options because of its higher fill ratio. The higher fill ratio enables additional breast reshaping options for women undergoing breast augmentation, reconstruction, or revision procedures.
Scott Whitcup, Allergan’s chief scientific officer, said thast over the past two years, the company has obtained FDA approval for three innovative and advanced breast implant qualities that represent the range of cutting edge products in Allergan’s expanding product portfolio.
The currently available range of the company’s Natrelle line includes Natrelle 410 anatomically shaped implants, classic round gel implants and saline implants. A total of 243 size options and a variety of projection styles are a part of the Natrelle breast implant line. This wide range ensures that every individual patient can receive the best combination and most customizable results with breast augmentation surgery.
Mark Jewell, former president of ASAPS said that the FDA approval of Natrelle Inspira breast implants in an important step in the reconstructive breast implant surgery in the US. He said that the Natrelle Inspira implants provide the option of fullness in breast shaping, and also serve as an effective revision option for millions of American women who have aging saline or silicone implants.
For more information on the surgical and non-surgical procedures and treatments by Board Certified Cosmetic Plastic Surgeons Dr. Reps Sundin and Dr. Burton Sundin please visit
Serving Northern Virginia, Washington DC, Vienna, McLean, Loudoun, Ashburn, Tysons Corner, Reston, Arlington, Chevy Chase, Richmond and surrounding communities.
